The most consequential development is the sustained elevation of short‑term Treasury yields (2‑year at 4.05%, 80th percentile) which translates into higher consumer financing costs and a direct drag on discretionary spend; for Edgewell, this amplifies price sensitivity in its razor and personal care portfolio, limiting the ability to offset volume declines with premium pricing.
A key risk is the continued rise in short‑term rates: a 100 bp increase in the 2‑year Treasury historically depresses Edgewell's revenue growth by roughly 1.3 percentage points (based on its -0.13 rate sensitivity), which would push year‑over‑year sales to below -18% and could erode operating margins as price concessions become necessary, tightening cash flow generation.
CPI decline: β_change=-0.4205 implies that a 1 pp drop in CPI growth could shave ~0.42 pp off revenue growth, eroding the primary tailwind.
Rate cuts: β_change=+0.1601 means falling rates reduce growth; a 100‑bp Fed easing would cut growth by ~0.16 pp.
Sustained CPI rise: With 100% sign stability on the change coefficient, continued inflation provides a reliable boost to revenue.
Higher rate environment: The positive β_level for rates (0.2107) suggests EPC can capture market share from cost‑constrained rivals when financing costs stay elevated.
M&A rumors deliver the most pronounced reaction (+5.8% on average), implying that positioning ahead of credible deal chatter can capture outsized upside, but only if the rumor passes a credibility filter (e.g., source credibility >70% and concurrent insider buying).
M&A rumors present a pronounced reversal risk: historically 70% of the initial +5.8% move evaporates within 60 days, translating to an average -4.0% correction if the deal fails to materialize; investors must size exposure accordingly and monitor deal‑confirmation milestones.
The largest downside drivers are the CPI coefficient (0.420) and unemployment coefficient (–0.193); a 2‑pp drop in CPI alone cuts revenue growth by ~0.84 pp, while a 4‑pp rise in unemployment adds another –0.77 pp under severe stress.
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net